These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 10709320)

  • 21. Ganglioside metabolism. Enzymology, Topology, and regulation.
    van Echten G; Sandhoff K
    J Biol Chem; 1993 Mar; 268(8):5341-4. PubMed ID: 8449895
    [No Abstract]   [Full Text] [Related]  

  • 22. Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy.
    Singh AP; Chaturvedi P; Batra SK
    Cancer Res; 2007 Jan; 67(2):433-6. PubMed ID: 17234748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomerase: a potential molecular marker and therapeutic target for cancer.
    Chang JY
    J Surg Oncol; 2004 Jul; 87(1):1-3. PubMed ID: 15221912
    [No Abstract]   [Full Text] [Related]  

  • 24. Cancer stem cell markers in common cancers - therapeutic implications.
    Klonisch T; Wiechec E; Hombach-Klonisch S; Ande SR; Wesselborg S; Schulze-Osthoff K; Los M
    Trends Mol Med; 2008 Oct; 14(10):450-60. PubMed ID: 18775674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gangliosides as components of lipid membrane domains.
    Sonnino S; Mauri L; Chigorno V; Prinetti A
    Glycobiology; 2007 Jan; 17(1):1R-13R. PubMed ID: 16982663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells.
    Ugorski M; Laskowska A
    Acta Biochim Pol; 2002; 49(2):303-11. PubMed ID: 12362971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gangliosides as carbohydrate antigens associated with cancer and their possible use in tumor immunotherapy].
    Horwacik I
    Przegl Lek; 2004; 61 Suppl 2():14-9. PubMed ID: 15686040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heat shock proteins as novel therapeutic targets in cancer.
    Soo ET; Yip GW; Lwin ZM; Kumar SD; Bay BH
    In Vivo; 2008; 22(3):311-5. PubMed ID: 18610741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of p53R2 and its role as potential target for cancer therapy.
    Wang X; Zhenchuk A; Wiman KG; Albertioni F
    Cancer Lett; 2009 Apr; 276(1):1-7. PubMed ID: 18760875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gangliosides turnover and neural cells function: a new perspective.
    Tettamanti G; Riboni L
    Prog Brain Res; 1994; 101():77-100. PubMed ID: 8029470
    [No Abstract]   [Full Text] [Related]  

  • 31. Preparation of radiolabeled gangliosides.
    Sonnino S; Nicolini M; Chigorno V
    Glycobiology; 1996 Jul; 6(5):479-87. PubMed ID: 8877367
    [No Abstract]   [Full Text] [Related]  

  • 32. Protection by gangliosides against glutamate excitotoxicity.
    Manev H; Guidotti A; Costa E
    Adv Lipid Res; 1993; 25():269-88. PubMed ID: 8103620
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of gangliosides in tumor progression.
    Hakomori S
    Prog Brain Res; 1994; 101():241-50. PubMed ID: 8029454
    [No Abstract]   [Full Text] [Related]  

  • 34. Gangliosides: potential diagnostic as well as therapeutic target for cancer.
    Saha S
    Indian J Exp Biol; 1999 Aug; 37(8):737-49. PubMed ID: 10709320
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunology of gangliosides.
    Ravindranath MH; Gonzales AM; Nishimoto K; Tam WY; Soh D; Morton DL
    Indian J Exp Biol; 2000 Apr; 38(4):301-12. PubMed ID: 11218805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discovery, biology, and drug development of sialyl Lea and sialyl Lex.
    Magnani JL
    Arch Biochem Biophys; 2004 Jun; 426(2):122-31. PubMed ID: 15158662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eliciting carbohydrate-specific immune response against sialosides: success and challenges.
    Ling CC; Bundle DR
    Future Med Chem; 2011 Apr; 3(5):519-34. PubMed ID: 21526894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of membrane-bound gangliosides in viable whole-cell vaccines.
    Ravindranath MH; Morton DL
    Cancer Invest; 1997; 15(5):491-9. PubMed ID: 9316631
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.